Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
非洲抗逆转录病毒治疗时代的卡波西肉瘤计划 (KEAAP)
基本信息
- 批准号:10598769
- 负责人:
- 金额:$ 92.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS related cancerAddressAfricaAfrica South of the SaharaBilateralCancer BiologyCancer CenterCancer PatientCancer Research InfrastructureCaringChronicCollaborationsCore FacilityCountryDetectionDiagnosisDiseaseEducational workshopEnsureEpidemicEtiologyFosteringFundingFutureGoalsHIVHIV-1HIV/AIDSHealth SciencesHospitalsHuman Herpesvirus 8Human ResourcesImmune responseImmunosuppressionIncidenceIndividualKaposi SarcomaLateralLeadLeadershipLearningLinkLouisianaMalignant NeoplasmsMediatingMentorsMolecularOceansOncologyOutcomePathogenesisPathologyPatientsPersonsPilot ProjectsPopulationPositioning AttributePublic HealthResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResidual stateStagingTanzaniaTeaching HospitalsTechnology TransferTissuesTrainingTraining ActivityTraining ProgramsTraining and InfrastructureUnited StatesUniversitiesViralVisionZambiaanticancer researchantiretroviral therapyclinical carehealth disparity populationsimmune activationlow and middle-income countriesmetabolomenext generationpreventprogramssuccess
项目摘要
There are currently over 1.2 million people in Zambia and 1.7 million in Tanzania who are living with HIV/AIDS.
Concomitant to the HIV epidemic, there is a high incidence of HIV/AIDS-associated malignancies (HIVAM) in
these two countries. Even in this era of antiretroviral therapy (ART) Kaposi sarcoma (KS) has remained one of
the most common HIVAM. This underscores a critical need for research in the context of ART-mediated
changes in the HIV epidemic so that we are better equipped to diagnose, manage, and prevent KS in sub-
Saharan Africa (SSA). To address this need, the overall vision of the “Kaposi Sarcoma in the Era of ART in
Africa Program (KEAAP)” is to build a collaborative network between the Cancer Diseases Hospital (CDH) and
University Teaching Hospitals (UTH) in Zambia, the Ocean Road Cancer Institute (ORCI) in Tanzania, and the
Stanley S Scott Cancer Center at the Louisiana State University Health Sciences Center-New Orleans
(LSUHSC-NO) to conduct cutting edge research that will lead to a better understanding of KS, and in parallel,
continue to enhance HIVAM and non-HIVAM research capacity in Zambia and Tanzania to meet the needs of
the cancer patients. KEAAP’s theme centers on the research gaps of the KS disease spectrum, from
detection, to care and outcomes, to deciphering KS pathogenesis and immune response towards achieving
KEAAP’s overall goal to prevent and curing the disease. KEAAP’s immediate objective is to further enhance
the cancer research infrastructure in CDH/UTH and ORCI through support for interdisciplinary and bilateral KS
research projects to address some of the research gaps in SSA: 1) KS diagnosis and disease staging, and
linking to care; 2) changes in the immune response and metabolomes in KS patients upon treatment; and 3)
identification and characterization of KSHV tissue reservoirs, and the effects of ART and HIV on these
reservoirs. This proposed consortium will provide diverse training activities in the U.S., Zambia, and Tanzania
to engage the next generation of low and middle income countries (LMICs) and U.S. cancer researchers,
increase local expertise, and enhance the transfer of technology. KEAAP’s goal will be accomplished through
the completion of three specific aims:1) Develop the cancer research infrastructure at UTH/CDH and ORCI
through the establishment and enhancement of three core facilities; 2) Provide an opportunity for former
Fogarty trained fellows to lead three hypothesis-driven KS research projects; 3) Develop a pipeline of next-
generation U.S. and LMICs cancer researchers through a) in-country workshops, b) pilot project funding, and
c) short-term U.S. and in-country training. KEAAP is high impact because it builds on successful ongoing
Fogarty and NCI training programs; it will implement a cross-disciplinary and tri-lateral research and training
program that are driven by our Tanzanian and Zambian collaborators with broad local support to ensure their
sustainability. The lessons learned will also benefit Louisiana HIV-1 and cancer research since the state has
the fifth largest population of people living with HIV, mostly among its health disparities population.
目前,赞比亚有120多万人感染艾滋病毒/艾滋病,坦桑尼亚有170万人感染艾滋病毒/艾滋病。
伴随着艾滋病毒的流行,艾滋病毒/艾滋病相关恶性肿瘤(HIVAM)的发病率很高,
这两个国家即使在这个抗逆转录病毒治疗(ART)的时代,卡波西肉瘤(KS)仍然是
最常见的艾滋病病毒这强调了在ART介导的背景下进行研究的迫切需要。
艾滋病毒流行的变化,使我们能够更好地诊断,管理和预防亚-
撒哈拉非洲。为了满足这一需求,“卡波西肉瘤在ART时代,
非洲计划(KEAAP)”是建立一个合作网络之间的癌症疾病医院(CDH)和
赞比亚的大学教学医院(UTH)、坦桑尼亚的海洋之路癌症研究所(ORCI)和
新奥尔良路易斯安那州立大学健康科学中心斯坦利·S·斯科特癌症中心
(LSUHSC-NO)进行尖端研究,这将导致更好地了解KS,同时,
继续加强赞比亚和坦桑尼亚的艾滋病毒/艾滋病和疟疾研究能力,以满足
癌症患者。KEAAP的主题集中在KS疾病谱的研究空白,从
检测,护理和结果,破译KS发病机制和免疫反应,以实现
KEAAP的总体目标是预防和治疗疾病。KEAAP的近期目标是进一步加强
CDH/UTH和ORCI的癌症研究基础设施,通过支持跨学科和双边KS
研究项目,以解决SSA的一些研究空白:1)KS诊断和疾病分期,
与护理相关; 2)KS患者治疗后免疫应答和代谢组的变化;以及3)
KSHV组织储库的鉴定和表征,以及ART和HIV对这些储库的影响。
水库这个拟议中的联盟将在美国提供各种培训活动,赞比亚和坦桑尼亚
吸引下一代中低收入国家和美国癌症研究人员,
增加当地专门知识,加强技术转让。KEAAP的目标将通过
完成三个具体目标:1)发展UTH/CDH和ORCI的癌症研究基础设施
通过建立和加强三个核心设施; 2)为前
福格蒂培训研究员领导三个假设驱动的KS研究项目; 3)开发下一个管道-
通过a)国内研讨会,B)试点项目资助,以及
3.短期美国和国内培训。KEAAP具有很高的影响力,因为它建立在成功的持续
Fogarty和NCI培训计划;它将实施跨学科和三边研究和培训
该计划由我们的坦桑尼亚和赞比亚合作者在当地广泛支持下推动,
持续发展吸取的教训也将有利于路易斯安那州的艾滋病毒-1和癌症研究,因为该州已经
艾滋病毒感染者人数居第五位,其中大多数是健康状况不佳的人口。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julius David Mwaiselage其他文献
Julius David Mwaiselage的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julius David Mwaiselage', 18)}}的其他基金
Tanzania AIDS Malignancies Training and Research International Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究国际计划 (TAMTRP)
- 批准号:
10650673 - 财政年份:2022
- 资助金额:
$ 92.06万 - 项目类别:
Tanzania AIDS Malignancies Training and Research Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究计划 (TAMTRP)
- 批准号:
10472142 - 财政年份:2022
- 资助金额:
$ 92.06万 - 项目类别:
Tanzania AIDS Malignancies Training and Research Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究计划 (TAMTRP)
- 批准号:
10601111 - 财政年份:2022
- 资助金额:
$ 92.06万 - 项目类别:
相似海外基金
A mixed methods approach to address multi-level barriers to care for migratory men living with HIV in South Africa
采用混合方法解决照顾南非艾滋病毒携带者移民男性的多层次障碍
- 批准号:
10403224 - 财政年份:2022
- 资助金额:
$ 92.06万 - 项目类别:
Using the EPIC model to build transdisciplinary communities of practice that effectively address urban resilience in Africa and Asia
使用 EPIC 模型建立跨学科实践社区,有效解决非洲和亚洲的城市复原力问题
- 批准号:
2103692 - 财政年份:2022
- 资助金额:
$ 92.06万 - 项目类别:
Standard Grant
A mixed methods approach to address multi-level barriers to care for migratory men living with HIV in South Africa
采用混合方法解决照顾南非艾滋病毒携带者移民男性的多层次障碍
- 批准号:
10689689 - 财政年份:2022
- 资助金额:
$ 92.06万 - 项目类别:
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/1 - 财政年份:2021
- 资助金额:
$ 92.06万 - 项目类别:
Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/2 - 财政年份:2021
- 资助金额:
$ 92.06万 - 项目类别:
Research Grant
An implementation science approach to address multi-level barriers to cancer screening among women living with HIV in South Africa
一种实施科学方法,以解决南非艾滋病毒感染妇女癌症筛查的多层次障碍
- 批准号:
10242935 - 财政年份:2020
- 资助金额:
$ 92.06万 - 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
- 批准号:
10267216 - 财政年份:2020
- 资助金额:
$ 92.06万 - 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
- 批准号:
10085144 - 财政年份:2020
- 资助金额:
$ 92.06万 - 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
- 批准号:
10438844 - 财政年份:2020
- 资助金额:
$ 92.06万 - 项目类别:
Teaching empowerment: Grass-roots educators' strategies to address gender equity in the context of the HIV epidemic in South Africa
教学赋权:基层教育工作者在南非艾滋病毒流行背景下解决性别平等问题的战略
- 批准号:
218055 - 财政年份:2010
- 资助金额:
$ 92.06万 - 项目类别:
Studentship Programs